Nuclera, the biotechnology company providing rapid access to functional proteins for drug discovery, has completed its first installations in Asia. Systems are now operational at the National ...

New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. We know the feeling — the feeling of waltzing down ...

This article explores how next-generation vaccines are expanding beyond infectious disease to target chronic conditions while ...